Excipients

Pharmaceutical excipients, which can be functional or inactive ingredients, work to enhance the medically relevant properties of the API. When used to promote ingredient qualities, excipients can be an asset for formulators to increase stability, bulk up the formulation, or enhance the therapeutic effects of the API. Below you can explore helpful resources including editorial coverage and webinars related to pharmaceutical excipients.

Executive Q&A: Samsung Biologics
Samsung Biologics continues to introduce new and innovative technology platforms with high-performing solutions that enhance therapeutic efficacy and proactively address evolving industry trends. S-AfuCHO™ is a cell line platform that can generate afucosylated antibodies that exhibit enhanced antibody-dependent cellular cytotoxity (ADCC) activity... read more
How AI is Becoming the Pharma Industry’s New R&D Partner
A simple headache often leads to a quick fix: a single ibuprofen. But the journey of that pill from concept to consumer is anything but straightforward. Drug development is a complex, time-consuming, and costly endeavor marked by countless trials and errors. Traditionally, this process has relied heavily on intuition and experience. However, a new ... read more
Pharmaceutical P.I.N. Points: Patent Innovation News
The purpose of this column is to highlight and summarize recent key patents in the pharmaceutical arena issued by the US Patent Office in June and July, 2024. read more

Infographic: Seven Softgel Myths
Softgels are a popular dose format among consumers thanks to their high swallowability and quick onset of action. Yet pharmaceutical developers may not even consider softgels. Why the disconnect? Here are seven popular misconceptions about softgels and the facts that disprove them. read more
eBook: Proven Applications Using Variable Pathlength Spectroscopy
This eBook provides details and insight into using Slope Spectroscopy and the CTech™ SoloVPE® variable pathlength spectroscopy system. The SoloVPE® system provides a rapid, robust, and repeatable, non-disruptive concentration measurement method for proteins, plasmid DNA, and nucleic acid modalities. Articles in this eBook ... read more
Analyses of Antibody Drugs Using Inert Ultra High Performance Liquid Chromatography
This article introduces analyses of monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) for quality control using an inert UHPLC system that is extremely resistant to mobile phases containing high salt concentrations. By suppressing the interaction between antibody drugs and stationary phase, the system delivered ... read more
Whitepaper: Key Considerations for Extracting Proteins from Recombinant Host Cells
In the biopharmaceutical industry, quality is pivotal. For a final product to meet quality standards, quality must be built into the production process. Biopharmaceuticals, however, are made from biologically sourced materials, which are inherently variable. read more
Whitepaper: How to Develop an Efficient Drug Formulation Process
Developing an efficient drug formulation development process requires expertise. Ascendia Pharmaceuticals, a leading specialty CDMO, has been recognized as a Partner of Choice by many drug companies because they have solved complex formulations for nearly a decade. Ascendia’s white paper details how to implement a drug discovery... read more